STAT3 and breast cancer: In contrast, STAT1 deficiency in STAT3Low mammary tumours (MT/Shc2F/2F) significantly accelerated their growth (Fig. 4e), suggesting that STAT1 selectively confers an immune surveillance response in mammary tumours with low STAT3 activity.